Category Archives: Interventional Cardiology

CHICAGO--(BUSINESS WIRE)-- Today, GE HealthCare (Nasdaq: GEHC) announced US FDA 510(k) clearance of Allia IGS Pulse - the latest addition to the companys image guided system (IGS) offerings. Allia IGS Pulse features a new imaging chain engineered to provide exceptional imaging at the right dose for visible impact in complex cardiology interventions regardless of patient size. This press release features multimedia. Continue reading →

The OpSens OptoWire is a pressure guidewire that uses a fiber optic sensor to assess stenoses in vessels, such as coronary arteries. Continue reading →

Cardiologists pay and workloads in the United States are mostly holding steady, according to new survey data reflecting the year 2022. And while there are some evolutions afoot, many of the expected changesa shift in practice setting due to an influx of private equity, for example, and growth in advanced intravascular imaginghavent yet made their mark. Continue reading →

The vast majority of people who have a minimally invasive transcatheter aortic valve replacement (TAVR) do not participate in recommended cardiac rehabilitation, a Michigan Medicine-led study found. Results published in JACC: Advances reveal that just 30.6% of patients who underwent TAVR participated in cardiac rehabilitation within 90 days after discharge.[1] Cardiac rehabilitation has been shown to improve the quality of life for so many patients after cardiovascular procedures, said first author Devraj Sukul, MD, MSc, interventional cardiologist at the University of Michigan Health Frankel Cardiovascular Center and clinical assistant professor of internal medicine-cardiology at U-M Medical School, said in a statement from the university. Continue reading →

3 benefits for interventional cardiologists using X/Twitter 1. Continue reading →

The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted by the discounting policy of the manufacturer Continue reading →

The Icahn School of Medicine at Mount Sinai has signed a memorandum of understanding with the Chiba Institute of Technology to use artificial intelligence to enhance clinical trials for cardiovascular disease, advance patient care and bring potential new treatments to heart disease patients more quickly. WHY IT MATTERS The affiliation between the two institutions aims to develop new strategies leveraging artificial intelligence to prevent and enhance the treatment of cardiovascular disease, a global health challenge, according to an announcement from Mount Sinai. Dr Continue reading →

The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted by the discounting policy of the manufacturer. Companies such as Opsens apply discounts for their devices based on their internal business strategy, inventory control, and monthly or quarterly sales targets Continue reading →

A newly piloted program from the Society for Cardiovascular Angiography & Interventions (SCAI), the leading society representing interventional cardiology, hopes to increase access and encourage interest in interventional cardiology early in students' medical careers. SCAI's Ready to Launch - Careers in Cardiology program is designed to introduce future physicians to the field of interventional cardiology through a half-day program where attendees will get the opportunity to have impactful conversations with nationally recognized interventional cardiologists, learning about training paths, barriers to care and solutions for the future, the importance of health equity, as well hands-on demonstrations showcasing the latest interventional therapies and technologies from leading industry representatives. This years program will host a diverse group of medical students from various colleges and universities in the Phoenix area on May 20 at the SCAI 2023 Scientific Sessions at the Phoenix Convention Center. Continue reading →

Artificial intelligence (AI) algorithms are being used more and more by cardiologists and other cardiovascular professionals. Continue reading →